rxstat › Shortages › Gadobenate Dimeglumine

Gadobenate Dimeglumine (Multihance) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Gadobenate Dimeglumine products are in shortage in Canada (1 of 1 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

A contrast agent used to improve the clarity of MRI scans.

Products affected
1 / 1
In shortage since
Sep 30, 2025
Reports on file
4
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
MULTIHANCE
529MG · SOLUTION · BRACCO IMAGING CANADA
DIN 02248302 · since Sep 30, 2025, no end estimate
Resolved
MULTIHANCE
529MG · SOLUTION · BRACCO IMAGING CANADA
DIN 02248302 · ended Aug 8, 2025 · This MultiHance format has been received, released and shipped to Canadian customers
Resolved
MULTIHANCE
529MG · SOLUTION · BRACCO IMAGING CANADA
DIN 02248302 · ended Aug 8, 2025 · This MultiHance format has been received, released and shipped to Canadian customers
Resolved
MULTIHANCE
529MG · SOLUTION · BRACCO IMAGING CANADA
DIN 02248302 · ended Feb 14, 2025 · Disruption of the manufacture of the drug.

What's happening

Gadobenate Dimeglumine is currently affected by an active shortage report filed with Health Canada by BRACCO IMAGING CANADA.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Gadobenate Dimeglumine is classified under “MAGNETIC RESONANCE IMAGING CONTRAST MEDIA” (ATC V08CA).

Recent changes

Common questions

What is Gadobenate Dimeglumine used for?

A contrast agent used to improve the clarity of MRI scans.

When will Gadobenate Dimeglumine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Gadobenate Dimeglumine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (magnetic resonance imaging contrast media)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Gadodiamide (Omniscan) Discontinued 0 of 1 reported products affected Gadoversetamide (Optimark) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.